SE9900941D0 - Novel retinoic acid derivatives and their use - Google Patents

Novel retinoic acid derivatives and their use

Info

Publication number
SE9900941D0
SE9900941D0 SE9900941A SE9900941A SE9900941D0 SE 9900941 D0 SE9900941 D0 SE 9900941D0 SE 9900941 A SE9900941 A SE 9900941A SE 9900941 A SE9900941 A SE 9900941A SE 9900941 D0 SE9900941 D0 SE 9900941D0
Authority
SE
Sweden
Prior art keywords
acid
retinoic acid
alpha
acid derivatives
novel retinoic
Prior art date
Application number
SE9900941A
Other languages
English (en)
Inventor
Oleg Strelchenok
Original Assignee
Nomet Management Serv Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9804537A external-priority patent/SE9804537D0/sv
Application filed by Nomet Management Serv Bv filed Critical Nomet Management Serv Bv
Priority to SE9900941A priority Critical patent/SE9900941D0/sv
Publication of SE9900941D0 publication Critical patent/SE9900941D0/sv
Priority to US09/471,105 priority patent/US6274747B1/en
Priority to US09/471,301 priority patent/US6197809B1/en
Priority to AT99958454T priority patent/ATE243701T1/de
Priority to AU15819/00A priority patent/AU765465B2/en
Priority to PCT/IB1999/002062 priority patent/WO2000042832A2/en
Priority to DE69909137T priority patent/DE69909137T2/de
Priority to DE69932187T priority patent/DE69932187T2/de
Priority to CNB998150878A priority patent/CN1149219C/zh
Priority to JP2000598508A priority patent/JP4515642B2/ja
Priority to AT99958453T priority patent/ATE332013T1/de
Priority to EP99958454A priority patent/EP1161436B1/en
Priority to AU15818/00A priority patent/AU766256B2/en
Priority to CA2358420A priority patent/CA2358420C/en
Priority to CA002358436A priority patent/CA2358436C/en
Priority to PCT/IB1999/002064 priority patent/WO2000047589A1/en
Priority to EP99958453A priority patent/EP1159756B1/en
Priority to IDW00200101363A priority patent/ID29246A/id
Priority to JP2000594306A priority patent/JP4643009B2/ja
Priority to US09/773,178 priority patent/US6358936B2/en
Priority to US09/854,064 priority patent/US6403554B2/en
Priority to HK02103709.4A priority patent/HK1041889B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/12—Esters of phosphoric acids with hydroxyaryl compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/091—Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
SE9900941A 1998-12-23 1999-03-16 Novel retinoic acid derivatives and their use SE9900941D0 (sv)

Priority Applications (22)

Application Number Priority Date Filing Date Title
SE9900941A SE9900941D0 (sv) 1998-12-23 1999-03-16 Novel retinoic acid derivatives and their use
US09/471,105 US6274747B1 (en) 1998-12-23 1999-12-21 Polyunsaturated fatty acid derivatives and their use
US09/471,301 US6197809B1 (en) 1998-12-23 1999-12-23 Compounds for the treatment of cancer
IDW00200101363A ID29246A (id) 1999-03-11 1999-12-28 Senyawa-senyawa baru untuk pengobatan kanker
JP2000594306A JP4643009B2 (ja) 1999-03-11 1999-12-28 癌治療のための新規化合物
JP2000598508A JP4515642B2 (ja) 1999-03-16 1999-12-28 多価不飽和脂肪酸誘導体およびその使用
AU15818/00A AU766256B2 (en) 1999-03-11 1999-12-28 New compounds for the treatment of cancer
PCT/IB1999/002062 WO2000042832A2 (en) 1999-03-11 1999-12-28 New compounds for the treatment of cancer
DE69909137T DE69909137T2 (de) 1999-03-16 1999-12-28 Polyungesättigte Fettsäurederivate und deren Verwendung in der Krebsbehandlung
DE69932187T DE69932187T2 (de) 1999-03-11 1999-12-28 Verbindungen für krebs-therapie
CNB998150878A CN1149219C (zh) 1999-03-11 1999-12-28 治疗癌症的新化合物
AT99958454T ATE243701T1 (de) 1999-03-16 1999-12-28 Polyungesättigte fettsäurederivate und deren verwendung in der krebsbehandlung
AT99958453T ATE332013T1 (de) 1999-03-11 1999-12-28 Verbindungen für krebs-therapie
EP99958454A EP1161436B1 (en) 1999-03-16 1999-12-28 Polyunsaturated fatty acid derivatives and their use in the treatment of cancer
AU15819/00A AU765465B2 (en) 1999-03-16 1999-12-28 Polyunsaturated fatty acid derivatives and their use
CA2358420A CA2358420C (en) 1999-03-11 1999-12-28 New compounds for the treatment of cancer
CA002358436A CA2358436C (en) 1999-03-16 1999-12-28 Polyunsaturated fatty acid derivatives and their use
PCT/IB1999/002064 WO2000047589A1 (en) 1998-12-23 1999-12-28 Polyunsaturated fatty acid derivatives and their use
EP99958453A EP1159756B1 (en) 1999-03-11 1999-12-28 Compounds for the treatment of cancer
US09/773,178 US6358936B2 (en) 1998-12-23 2001-01-30 Compounds for the treatment of cancer
US09/854,064 US6403554B2 (en) 1998-12-23 2001-05-11 Polyunsaturated fatty acid derivatives and their use
HK02103709.4A HK1041889B (zh) 1999-03-11 2002-05-16 治療癌症的新化合物

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9804537A SE9804537D0 (sv) 1998-12-23 1998-12-23 New composition
SE9900941A SE9900941D0 (sv) 1998-12-23 1999-03-16 Novel retinoic acid derivatives and their use

Publications (1)

Publication Number Publication Date
SE9900941D0 true SE9900941D0 (sv) 1999-03-16

Family

ID=26663468

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9900941A SE9900941D0 (sv) 1998-12-23 1999-03-16 Novel retinoic acid derivatives and their use

Country Status (3)

Country Link
US (2) US6274747B1 (sv)
SE (1) SE9900941D0 (sv)
WO (1) WO2000047589A1 (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000032175A2 (en) * 1998-12-02 2000-06-08 Pfizer Products Inc. METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
GB0016045D0 (en) * 2000-06-29 2000-08-23 Laxdale Limited Therapeutic combinations of fatty acids
AU2001268007A1 (en) * 2000-07-12 2002-01-21 Ardenia Investments Ltd. Novel cytotoxic compounds and their use
US7341717B2 (en) * 2001-04-13 2008-03-11 Gpc Biotech Ag Therapeutic targets for treatment of HCV infections, methods of treating HCV infections and compounds useful therefor
EP1534672B1 (en) * 2002-07-23 2013-05-01 Ardenia Investments Ltd. Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents
WO2004050101A2 (en) * 2002-11-29 2004-06-17 Gpc Biotech Ag Formulations useful against hepatitis c virus infections
CA2671938C (en) 2006-12-10 2017-10-17 Chongxi Yu Transdermal delivery systems of beta-lactam antibiotics
PT2125697T (pt) 2007-01-15 2016-10-18 Yu Chongxi Pró-fármacos solúveis em água positivamente carregados de retinóides e compostos tipo retinóide com taxas de penetração na pele muito altas
WO2009149496A1 (en) * 2008-06-10 2009-12-17 Central Northern Adelaide Health Service Treatment of diabetes and complications thereof and related disorders
US9969751B2 (en) 2009-06-10 2018-05-15 Techfields Pharma Co., Ltd. High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
CA3189252A1 (en) 2012-05-16 2013-11-21 Techfields Pharma Co., Ltd. High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
BR112021015307A2 (pt) * 2019-02-21 2021-11-09 Centre Nat Rech Scient Vetores moleculares estruturados e usos dos mesmos
WO2024068553A1 (en) 2022-09-26 2024-04-04 Vivesto Ab Solubilizing compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9802162D0 (sv) * 1998-06-17 1998-06-17 Nomet Management Services Bv Immunostimulating composition

Also Published As

Publication number Publication date
US6274747B1 (en) 2001-08-14
WO2000047589A1 (en) 2000-08-17
US20010037032A1 (en) 2001-11-01
US6403554B2 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
SE9900941D0 (sv) Novel retinoic acid derivatives and their use
NO931390D0 (no) Vandig gelbaerer for retinoider
DE69720787D1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
BR0013157A (pt) Composições farmacêuticas e nutricionais contendo ácidos graxos essenciais e agentes de abaixamento da homocisteìna
BR0112073A (pt) Combinações terapêuticas de ácidos graxos
ES2168136T3 (es) Productos de reticulado de biopolimeros que contienen grupos amino.
ATE239717T1 (de) Ester und amide von nicht-steroidalen entzündungs-hemmenden carbonsäuren die als anti-oxidantien 5- lipoxygenase-hemmer und nicht-steroidale entzündungs-hemmende mittel verwendet werden können
ATE217883T1 (de) Pentapeptid-amide und -ester, die menslichen krebs hemmen
ATE225371T1 (de) Vernetzte hyaluronsäure und ihre medizinischen verwendungen
FR2754820B1 (fr) Le (-)hydroxycitrate de magnesium, procede de preparation, applications, et compositions notamment pharmaceutiques le renfermant
HN2000000224A (es) Aminoacidos biciclicos como agentes farmaceuticos
RU95106674A (ru) Полиеновые соединения, фармацевтическая и косметическая композиция на их основе
DE60022327D1 (de) Lipoxinverbindungen und ihre anwendung
ES2148593T3 (es) Compuestos retinoides trienoicos novedosos y metodos.
PT824152E (pt) Producao microbiana de vitamina b12 e producao e utilizacao de composicoes contendo elevadas concentracoes de actividade de vitamina b12
AR005468A1 (es) Nuevos derivados de benzoilguanidina, procedimientos para su preparacion y su empleo en la preparacion de medicamentos.
DK0977560T3 (da) Ibuprofen-thioestere som hæmmere af den Nf-kappaB-afhængige dannelse af betændelses og smertemediatorer (CoA-thioestere af arylpropionsyrer, aryleddikesyrer og salicylater som hæmmere af den Nf-kappaB-afhængige dannelse af betændelses og smertemediatorer)
ES2143705T3 (es) Preparaciones cosmeticas y/o farmaceuticas que contienen tensioactivos sacaricos y gliceridos parciales de acidos grasos.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
DE3864691D1 (de) Thiazolidin-4-carbonsaeurederivat, seine herstellung und pharmazeutische zusammensetzungen, die dieses enthalten.
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
ES2141978T3 (es) Retinoides triciclicos, metodos para su produccion y uso.
ATE243701T1 (de) Polyungesättigte fettsäurederivate und deren verwendung in der krebsbehandlung
ES2118248T3 (es) Esteres y amidas de 9-cloro-prostaglandina y su empleo para preparar medicamentos.
PT745081E (pt) Derivados de dissulfureto de inda-2-mercaptoacetilamida uteis como inibidores da encefalinase